LYBALVI

LIVE

Serial Number

87700839

Owner

Alkermes Pharma Ireland Limited

Attorney

Norm J. Rich

First Use Date

Apr 19, 2021

Filing Date

Nov 29, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LYBALVI Trademark

Serial Number: 87700839 • Registration: 6428572

LYBALVI is a trademark filed by Alkermes Pharma Ireland Limited on November 29, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Alkermes Pharma Ireland Limited (87 trademarks)

Connaught House
Dublin 4 , IE

Entity Type: 99

Legal Representation

Attorney of Record

Norm J. Rich

2,983 trademarks filed View all →

Correspondence Address

Norm J. Rich FOLEY & LARDNER LLP

3000 K STREET, N.W.

SIXTH FLOOR

WASHINGTON, DC 20007

UNITED STATES

Trademark Details

Filing Date

November 29, 2017

Registration Date

July 20, 2021

First Use Anywhere

April 19, 2021

First Use in Commerce

April 19, 2021

Published for Opposition

April 24, 2018

Goods & Services

Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 24, 2026 ASCK

REGISTERED-PRINCIPAL REGISTER

Jul 20, 2021 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 17, 2021 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 16, 2021 CNPR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 17, 2021 GNRN

NON-FINAL ACTION E-MAILED

May 17, 2021 GNRT

SU - NON-FINAL ACTION - WRITTEN

May 17, 2021 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Apr 26, 2021 SUPC

USE AMENDMENT FILED

Apr 22, 2021 IUAF

TEAS STATEMENT OF USE RECEIVED

Apr 22, 2021 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 10, 2020 EXRA

SOU EXTENSION 5 GRANTED

Nov 9, 2020 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 9, 2020 AITU

SOU EXTENSION 5 FILED

Oct 29, 2020 EXT5

SOU TEAS EXTENSION RECEIVED

Oct 29, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 9, 2020 EXRA

SOU EXTENSION 4 GRANTED

May 7, 2020 EX4G

SOU EXTENSION 4 FILED

May 7, 2020 EXT4

SOU TEAS EXTENSION RECEIVED

May 7, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 12, 2019 EXRA

SOU EXTENSION 3 GRANTED

Nov 8, 2019 EX3G

SOU EXTENSION 3 FILED

Nov 8, 2019 EXT3

SOU TEAS EXTENSION RECEIVED

Nov 8, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 4, 2019 EXRA

SOU EXTENSION 2 GRANTED

May 31, 2019 EX2G

SOU EXTENSION 2 FILED

May 31, 2019 EXT2

SOU TEAS EXTENSION RECEIVED

May 31, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 12, 2018 EXRA

SOU EXTENSION 1 GRANTED

Dec 10, 2018 EX1G

SOU EXTENSION 1 FILED

Dec 10, 2018 EXT1

SOU TEAS EXTENSION RECEIVED

Dec 10, 2018 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 19, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 24, 2018 NPUB

PUBLISHED FOR OPPOSITION

Apr 24, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 4, 2018 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 15, 2018 CNSA

ASSIGNED TO EXAMINER

Mar 13, 2018 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 8, 2017 NWOS

NEW APPLICATION ENTERED

Dec 2, 2017 NWAP

Related Trademarks

More from this Owner

MURAL ONCOLOGY

More in Same Class

JUNLEBAO